MODERATE RISK OF HEPATITIS B VIRUS REACTIVATION IN HBsAg-/HBcAb+ CARRIERS RECEIVING RITUXIMAB FOR RHEUMATOID ARTHRITIS

被引:0
|
作者
Kuo, Meng Hsuan [1 ]
Tseng, Chi-Wei [2 ]
Lee, Chi-Hui [1 ]
机构
[1] Dalin Tzu Chi Hosp, Pharm, Chiayi, Taiwan
[2] Tzuchi Univ, Sch Med, Hualien, Taiwan
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1028
引用
收藏
页码:624A / 624A
页数:1
相关论文
共 50 条
  • [21] Low Risk Of Hepatitis B Virus Surface Antigen Seroreversion In HBsAg Negative/Anti-Hbc Positive Carriers Undergoing Rituximab For Rheumatoid Arthritis
    Varisco, Valentina
    Vigano', Mauro
    Batticciotto, Alberto
    Lampertico, Pietro
    Marchesoni, Antonio
    Gibertini, Patrizia
    Pellerito, Raffaele
    Rovera, Guido
    Caporali, Roberto
    Todoerti, Monica
    Covelli, Michele
    Notarnicola, Antonella
    Sarzi-Puttini, Piercarlo
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1201 - S1201
  • [22] LOW RISK OF HEPATITIS B VIRUS SURFACE ANTIGEN SEROREVERSION IN HBSAG NEGATIVE, ANTI-HBC POSITIVE CARRIERS UNDERGOING RITUXIMAB FOR RHEUMATOID ARTHRITIS
    Varisco, V.
    Vigano, M.
    Batticciotto, A.
    Lampertico, P.
    Marchesoni, A.
    Gibertini, P.
    Pellerito, R.
    Rovera, G.
    Caporali, R.
    Todoerti, M.
    Covelli, M.
    Notarnicola, A.
    Sarzi-Puttini, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 686 - 687
  • [23] MONITORING FOR REACTIVATION OF HEPATITIS B VIRUS IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING IMMUNOSUPRESSIVE THERAPY
    Iwase, H.
    Kanayama, Y.
    Inagaki, H.
    Futamura, N.
    Saeki, M.
    Saeki, T.
    Yoshida, A.
    Murata, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 448 - 448
  • [24] Rituximab-induced hepatitis C virus reactivation in rheumatoid arthritis
    Lin, Ko-Ming
    Lin, Jing-Chi
    Tseng, Wen-Yi
    Cheng, Tien-Tsai
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2013, 46 (01) : 65 - 67
  • [25] REACTIVATION OF HEPATITIS B VIRUS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Iwase, H.
    Kanayama, Y.
    Inagaki, H.
    Murase, A.
    Saeki, M.
    Shimizu, S.
    Saeki, T.
    Murata, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 910 - 910
  • [26] Reactivation of resolved hepatitis B during rituximab therapy for rheumatoid arthritis
    Ghrenassia, Etienne
    Mekinian, Arsene
    Rouaghe, Samir
    Ganne, Nathalie
    Fain, Olivier
    JOINT BONE SPINE, 2012, 79 (01) : 100 - 101
  • [27] The Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Receiving Tocilizumab: A Systematic Review and Meta-Analysis
    Ko, Ping-Hung
    Kuo, Meng Hsuan
    Kao, I-Ting
    Wu, Chen-Yi
    Tseng, Chih-Wei
    Shao, Shih-Chieh
    VIRUSES-BASEL, 2024, 16 (01):
  • [28] Prevalence of reactivation of hepatitis B virus replication in rheumatoid arthritis patients
    Urata, Yukitomo
    Uesato, Ryoko
    Tanaka, Dai
    Kowatari, Kenji
    Nitobe, Taisuke
    Nakamura, Yoshihide
    Motomura, Shigeru
    MODERN RHEUMATOLOGY, 2011, 21 (01) : 16 - 23
  • [29] Hepatitis B reactivation in a patient with rheumatoid arthritis with antibodies to hepatitis B surface antigen treated with rituximab.
    Gigi, E.
    Georgiou, T.
    Sarantopoulos, A.
    Mougiou, D.
    Boura, P.
    Raptopoulou-Gigi, M.
    HIPPOKRATIA, 2013, 17 (01) : 91 - 93
  • [30] Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving immunosuppressive therapy for glomerulonephritis: a retrospective analysis
    Jing Fang
    Wenge Li
    Xiangxin Peng
    Zhao Tan
    Min Tan
    Cong Zhang
    Wenbo Wang
    Zhihong Xu
    Gumin Zhou
    International Urology and Nephrology, 2017, 49 : 475 - 482